Results 191 to 200 of about 31,180 (210)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis

Journal of Clinical Medicine, 2021
Andrzej Pawlik, Sylwia Słuczanowska-Głąbowska, Kamila Szumilas   +2 more
exaly  

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Journal of Inflammation Research, 2023
Jin-Ying Lin
exaly  

Structural basis of Janus kinase trans-activation

Cell Reports, 2023
Kenan Garcia, Stevan R Hubbard, Caleb R. Glassman   +2 more
exaly  

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study

Journal of the American Academy of Dermatology, 2023

exaly  

Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

Journal of the American Academy of Dermatology, 2022
John Frew
exaly  

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Janus kinases in immune cell signaling

Immunological Reviews, 2009
Kamran Ghoreschi, John O'Shea, Arian Laurence   +2 more
exaly  

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski, John C Vanrens, Michael P Clark   +2 more
exaly  

Ruxolitinib: An Oral Janus Kinase 1 and Janus Kinase 2 Inhibitor in the Management of Myelofibrosis

Postgraduate Medicine, 2013
Srdan Verstovsek
exaly